Basic & Clinical Medicine ›› 2019, Vol. 39 ›› Issue (7): 949-953.

Previous Articles     Next Articles

PRMT1 regulates the expression of c-myc through C/EBPα in breast cancer cell line MDA-MB-231

  

  • Received:2019-04-28 Revised:2019-05-21 Online:2019-07-05 Published:2019-07-02
  • Contact: Qun Lin E-mail:578786213@qq.com

Abstract: Objective To investigate how PRMT1 regulates c-myc in breast cancer cells. Methods The expression of c-myc was detected in protein and mRNA levles in overexpressing C/EBPα and knocking down PRMT1 of MDA-MB-231 cells. ChIP-qPCR and EMSA were performed to detect the binding ability of C/EBPα to the promoter of c-myc. The promoter of c-myc activity regulated by PRMT1 and C/EBPα was detected by dual-luciferase report system. Results The expression of c-myc declined dramatically after overexpressing C/EBPα and knocking down PRMT1. The promoter of c-myc activity repressed by C/EBPα was weakened obviously after the methylation sites of C/EBPα at R35F, R156F and R165F were mutated. The regulation of c-myc by PRMT1 has a little effect after the methylation sites of C/EBPα at R35K, R156K and R165K were mutated. Conclusions PRMT1 regulates the transcription of c-myc by methylation of C/EBPα.

Key words: Key words:PRMT1, C/EBPα, c-Myc, Arginine methylation

CLC Number: